Ziopharm Oncology, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Ziopharm Oncology, Inc.
Quantité totale PI 13
Rang # Quantité totale PI 120 469
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 720 001
Symbole boursier
ISIN US98973P1012
Capitalisation 529M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 0
0 1
11 0
0
 
Dernier brevet 2021 - Methods of treating glioblastoma
Premier brevet 1997 - N-substituted indole-3 glyoxylam...
Dernière marque 2013 - ZIOPHARM
Première marque 2013 - ZIOPHARM

Industrie (Classification de Nice)

Derniers inventions, produits et services

2020 Invention Methods of treating glioblastoma. The present invention provides methods of treating glioblastoma...
2016 Invention Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof. Disclosed h...
2015 Invention Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof. Disclosed he...
2014 Invention Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents. + represents an ammon...
2013 Invention Salts of isophosphoramide mustard and analogs thereof. Disclosed herein are crystalline compounds...
P/S Pharmaceuticals for the treatment of cancer.
Invention Nanoparticulate compositions of tubulin inhibitor compounds. The present invention is directed t...
Invention Indibulin therapy. The invention provides combination therapy, wherein one or more other therape...
Invention Pharmaceutical formulations of indibulin and uses thereof. The present invention relates to pharm...
Invention Pharmaceutical formulations of indibulin and uses thereof. The present invention relates to phar...
Invention Combination therapy with organic arsenicals. The invention provides a combination therapy wherei...
Invention Combination therapy including isophosphoramide mustard, analogs, or salts thereof. In one aspect,...
Invention Combination therapy including isophosphoramide mustard, analogs, or salts thereof. In one aspect...
2010 Invention Pharmaceutical formulations for indibulin. In certain embodiments, the invention relates to phar...
Invention Pharmaceutical formulations for indibulin. In certain embodiments, the invention relates to pharm...
2009 Invention Organoarsenic compounds and methods for the treatment of cancer. A method for treating a lymphoma...
Invention Organoarsenic compounds and methods for the treatment of cancer.

A method for tre...
2008 Invention Compounds and methods for the treatment of cancer. The present invention provides methods of syn...
Invention Compounds and methods for the treatment of cancer. The present invention provides methods of synt...
Invention Combination therapy with organic arsenicals. The invention provides a combination therapy wherein...
Invention Salts of isophosphoramide mustard and analogs thereof. + represents a hydroxylated aliphatic ammo...
2007 Invention Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with fur...
Invention Method for controlling angiogenesis in animals. Organic arsenical compounds are useful to inhibit...
Invention Method for controlling angiogenesis in animals. Disclosed are methods for the inhibition of angio...
Invention Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties. The invention ...
Invention Indolyl-3-glyoxylic acid derivatives having antitumor action. The invention relates to the use ...
Invention Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents. The present disclosur...
2006 Invention Compounds and methods for the treatment of cancer. The present invention provides organic arsenic...
Invention Compounds and methods for the treatment of cancer.
The present invention provides orga...
Invention Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin. The present invention r...
2005 Invention Pharmaceutical presentation form for oral administration of a poorly soluble active compound, pro...
Invention Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improv...
2003 Invention Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties. The invention re...
Invention N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/im...
2002 Invention N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/imm...
2001 Invention United states patent office. The invention relates to the use of N-substituted indole-3-glyoxylam...
1999 Invention Indolyl-3-glyoxylic acid derivatives having antitumor action. and to a pharmaceutical composition...
1997 Invention N-substituted indole-3 glyoxylamides having anti-asthmatic antiallergic and immunosuppressant/imm...